Opinion

Our Readiness for the Attack of the Flu Bug

October 11, 2009

Getting Ready for Comparative Effectiveness Research

August 22, 2009

The most basic impulse behind CER is the desire to control healthcare costs. The implications for the biopharma industry could be significant

Information Security in Healthcare and Life Sciences Is Facing a Tipping Point

August 22, 2009

Are you prepared?

Revisiting 'To Err Is Human'

August 22, 2009

Preventable medical and medication errors should figure more prominently in the current debate on healthcare reform

Rx-360, a Global Anti-Counterfeiting Consortium, Gains Momentum

July 05, 2009

Coverage -- Access: Pharma Must Play Activist Role in Health Reform Efforts

July 05, 2009

Private and public sectors can collaborate to achieve meaningful reform

Psychoactive Drugs: Getting the Whole Support Team on Board

July 05, 2009

More so than other classes of drugs, making choices about drugs for mental health conditions require everyone around the patient to be well informed

Drug Wholesalers and the Generic Price War

June 13, 2009

Reshaping Biotechnology's Financing Relay Race

June 13, 2009

The current economic downturn may fuel the creation of new, more sustainable business models

Comparative Effectiveness: Tools, Not Rules

June 13, 2009